Cardiac Complications in Patients with COVID-19: An Integrative Literature Review
DOI:
https://doi.org/10.5294/aqui.2020.20.4.3Palabras clave:
Infecciones por coronavirus, atención hospitalaria, cardiología, cuidados críticos, atención de enfermería.Resumen
Complicaciones cardíacas en pacientes con covid-19: revisión integrativa de la literatura
Complicações cardíacas em pacientes com covid-19: revisão integrativa da literatura
Objetivo: verificar a partir de la literatura cuáles son las principales complicaciones cardíacas en pacientes con covid-19, durante el tratamiento en una unidad hospitalaria.
Materiales y método: revisión integradora, realizada mediante la búsqueda de estudios en ocho bases de datos nacionales e internacionales. La muestra final estuvo conformada por 16 estudios publicados entre enero y mayo de 2020, que fueron sometidos a evaluación estructural, utilizando las Case Report Guidelines, para los reportes de caso, y el Strengthening the Reporting of Observational Studies in Epidemiology, para los estudios observacionales.
Resultados: las principales complicaciones cardíacas fueron principalmente eventos obstructivos, entendidos aquí por infarto agudo de miocardio, seguidos de arritmias severas e insuficiencia cardíaca, todo debido a la condición de hiperinflamación por infección viral.
Conclusiones: el conocimiento sobre las complicaciones cardíacas durante el tratamiento de la covid-19 ha cobrado importancia, ya que puede colaborar para la adopción de protocolos de tratamiento más efectivos y orientar la asistencia brindada por los profesionales de la salud, con el fin de identificar dichas complicaciones e intervenir tempranamente.
To reference this article / Para citar este artigo / Para citar este artículo
Maier SRO, Rodrigues JPF, Sudré MRS, Dessotte CAM. Cardiac Complications in Patients with COVID-19: An Integrative Literature Review. Aquichan. 2020;20(4):e2043. DOI: https://doi.org/10.5294/aqui.2020.20.4.3
Recibido: 18/08/2020
Aceptado: 25/09/2020
Publicado: 04/12/2020
Descargas
Citas
Lei S, Jiang F, Sua W, Chend C, Chene J, Meif W et al. Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection. E Clinical Medicine. 2020;21:e100331. Available from: https://doi.org/10.1016/j.eclinm.2020.100331
Guo T, Fan Y, Chen M, Wu X, Zhang L, He T et al. Cardiovascular implications of fatal outcomes of patients with Coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;27:e201017. Available from: https://doi.org/10.1001/jamacardio.2020.1017
Cui J, Li F, Shi Z-L. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2019; 17:181-92. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097006/
World Health Organization. Pneumonia of unknown cause-China. 2020. Available from: https://www.who.int/csr/don/05-april-2020-pneumonia-of-unkown-cause-china/en/
World Health Organization. Novel coronavirus-China. 2020. Available from: https://www.who.int/csr/don/12-april-2020-novel-coronavirus-china/en/
Gralinski LE, Menachery VD. Return of the Coronavirus: 2019-nCoV. Viruses. 2020;12(2):e135. Available from: https://doi.org/10.3390/v12020135
Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382:1199-207. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121484/
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet. 2020;395(1):507-13. DOI: https://doi.org/10.1016/S0140-6736(20)30211-7
Gautret P, Lagier J-C, Parola P, Hoang VT, Meddeb L, Mailhe M et al. Hydroxychloroquine and Azithromycin as a Treatment of COVID-19: Results of an Open-Label Non-Randomized Clinical Trial. Int J Antimicrob Agents. 2020;e105949 Available from: https://doi.org/10.1016/j.ijantimicag.2020.105949
Million M, Lagier J-C, Gautret P, Colson P, Fournier P-E, Amrane S et al. Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France. Travel Medicine and Infectious Disease. 2020;35:e101738. Available from: https://doi.org/10.1016/j.tmaid.2020.101738
Roden DM, Harrington RA, Poppas A, Russo AM. Considerations for drug interactions on QTc in exploratory COVID-19 (Coronavirus Disease 2019) Treatment. Circulation. 2020;141:e906-7. DOI: https://doi.org/10.1161/CIRCULATIONAHA.120.047521
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395(10223):497-506. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7159299/
Inciardi RM, Lupi L, Zaccone G, Italia L, Raffo M, Tomasoni D et al. Cardiac involvement in a patient with Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):819-24. DOI: https://doi.org/10.1001/jamacardio.2020.1096
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z et al. Clinical course and risk factors for mortality of adult in patients with COVID-19 in Wuhan, China: A retrospective cohort study. The Lancet. 2020;395:1054-62. DOI: https://doi.org/10.1016/S0140-6736(20)30566-3
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang Z et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA Cardiol. 2020;323(11):10619. DOI: https://doi.org/10.1001/jama.2020.1585
Zeng J, Liu Y, Yuan J, Wang F, Wu W, Li J et al. First case of COVID‑19 complicated with fulminant myocarditis: A case report and insights. Infection. 2020;10(ahead of print):1-5. DOI: https://doi.org/10.1007/s15010-020-01424-5
Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;e200950. DOI: https://doi.org/10.1001/jamacardio.2020.0950
Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. 2020;8(4):e21. DOI: https://doi.org/10.1016/S2213-2600(20)30116-8
Mendes KDS, Silveira RCCP, Galvão CM. Revisão integrativa: método de pesquisa para a incorporação de evidências na saúde e na enfermagem. Texto Contexto Enferm. 2008;17(4):758-64. DOI: https://dx.doi.org/10.1590/S0104-07072008000400018
Mendes KDS, Silveira RCCP, Galvão CM. Uso de gerenciador de referências bibliográficas na seleção dos estudos primários em revisão integrativa. Texto Contexto Enferm. 2019; 28:e20170204. DOI: https://dx.doi.org/10.1590/1980-265X-TCE-2017-0204
Melnyk BM, Fineout-Overholt E. Making the case for evidence based practice. Melnyk BM, Fineout-Overholt E, organizadores. Evidence based practice in nursing & health care. A guide to best practice. Philadelphia (US): Lippincot Williams & Wilkins; 2005. p. 3-24.
Santos CMC, Pimenta CAM, Nobre MRC. The PICO strategy for the research question construction and evidence search. Rev Latino-am Enfermagem. 2007;15(3):508-11. Available from: http://www.scielo.br/pdf/rlae/v15n3/v15n3a23.pdf
Simera I, Altman DG, Moher D, Schulz KF, Hoey J. Guidelines for Reporting Health Research: The EQUATOR Network’s Survey of Guideline Authors. PLoS Med. 2008;5(6): e139. DOI: https://doi.org/10.1371/journal.pmed.0050139
Von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. STROBE Initiative. J Clin Epidemiol. 2008;61(4):344-9. Available from: https://www.ncbi.nlm.nih.gov/pubmed/18313558
Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D. The CARE guidelines: Consensus-based clinical case reporting guideline development. Headache. 2013;53(10):1541-7. Available from: https://www.ncbi.nlm.nih.gov/pubmed/24266334
Moher D, Shamseer L, Clarke M, Ghersi D, Liberrati A, Petticrew M et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Bio Med Central. 2015;4(1):1-9. Available from: https://www.ncbi.nlm.nih.gov/pubmed/25554246
Aromataris E, Munn Z. Chapter 1: JBI Systematic Reviews. In: Aromataris E, Munn Z, editores. JBI Reviewer’s Manual. JBI; 2017. DOI: https://doi.org/10.46658/JBIRM-17-01
Inciardi RM, Adamo M, Lupi L, Cani DS, Pasquale MD, Tomasoni D et al. Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy. European Heart Journal. 2020;41:1821-9. DOI: https://doi.org/10.1093/eurheartj/ehaa388
Li M, Dong Y, Wang H, Guo W, Zhou H, Zhang Z et al. Cardiovascular disease potentially contributes to the progression and poor prognosis of COVID-19. Nutrition, Metabolism & Cardiovascular Diseases. 2020;30(7):1061-7. DOI: https://doi.org/10.1016/j.numecd.2020.04.013
Xiong F, Tang H, Liu L, Tu C, Tian JB, Lei CT et al. Clinical characteristics of and medical interventions for COVID-19 in hemodialysis patients in Wuhan, China. JASN. 2020; ASN.2020030354. DOI: https://doi.org/10.1681/ASN.2020030354
Zhang J, Lu S, Wang X, Jia X, Li J, Lei H et al. Do underlying cardiovascular diseases have any impact on hospitalised patients with COVID-19? Heart. 2020;106:1119-21. DOI: http://dx.doi.org/10.1136/heartjnl-2020-317110
Zhen Y, Xua H, Yanga M, Zenga Y, Chena H, Liu R et al. Epidemiological characteristics and clinical features of 32 critical and 67 noncritical cases of COVID-19 in Chengdu. Journal of Clinical Virology. 2020;127:104366. DOI: https://doi.org/10.1016/j.jcv.2020.104366
Wan S, Xiang Y, Fang W, Zheng Y, Li B, Hu Y et al. Clinical features and treatment of COVID-19 patients in northeast Chongqing. Journal of Medical Virology. 2020;92(7):797-806. Available from: https://pubmed.ncbi.nlm.nih.gov/32198776/
Rothstein ES, Welch TD, Andrus BW, Jayne JE. Management of a patient presenting with anterior STEMI with concomitant COVID-19 infection early in the course of the U.S. pandemic. Catheter Cardiovasc Interv. 2020;1-6. DOI: https://doi.org/10.1002/ccd.28967
Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential effects of coronaviruses on the cardiovascular system. JAMA Cardiol. 2020;5(7):831-40. DOI: https://doi:10.1001/jamacardio.2020.1286
Ferguson J, Rosser JI, Quintero O, Scott J, Subramanian A, Gumma M et al. Characteristics and outcomes of coronavirus disease patients under nonsurge conditions, northern California, USA, March-April 2020. Emerg Infect Dis. 2020;26(8):1679-85. DOI: https://doi.org/10.3201/eid2608.201776
Bonow RO, Fonarow GC, O’Gara PT, Yancy CW. Association of coronavirus disease 2019 (COVID-19) with myocardial injury and mortality. JAMA Cardiol. 2020;5(7):751-3. DOI: http://doi.org/10.1001/jamacardio.2020.1105
Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffmann J et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020,27(7):E1-9. DOI: https://doi.org/10.1001/jamacardio.2020.3557
Ferrari F. COVID-19: dados atualizados e sua relação com o sistema cardiovascular. Arq Bras Cardiol. 2020;114(5):823-6. DOI: https://doi.org/10.36660/abc.20200215
Askin L, Tanrıverdi O, Askin H S. O efeito da doença de coronavírus 2019 nas doenças cardiovasculares. Arq Bras Cardiol. 2020;114(5):817-22. DOI: https://doi.org/10.36660/abc.20200273
Pacileo M, Giallauria F, Savarese C, Cirillo T, Crescibene F, Lorenzo AD et al. The role of echocardiography in SARS-CoV-2 pandemic: A compromise among appropriateness, safety and clinical impact. Monaldi Archives for Chest Disease. 2020;90:1358. Available from: https://www.monaldi-archives.org/index.php/macd/article/view/1358/1028
Lippi G, Lavie CJ, Sanchis-Gomar F. Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis. Prog Cardiovasc Dis. 2020;63(3):390-1. DOI: https://doi.org/10.1016/j.pcad.2020.03.001
Bangalore S, Sharma A, Slotwiner A, Yatskar L, Harari R, Shah B et al. ST-Segment elevation in patients with Covid-19 — A case series. N Engl J Med. 2020;382:2478-80. DOI: https://doi.org/10.1056/NEJMc2009020
Wei-jie G, Zheng-yi N, Yu H, Wen-hua L, Chun-quan O, Jian-xing H et al. Clinical characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708-20. Available from: https://www.nejm.org/doi/pdf/10.1056/NEJMoa2002032
Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020;18(5):1094-9. DOI: https://doi.org/10.1111/jth.14817
Liu Z, Xue XB, Zhi XZ. The epidemiological characteristics of an outbreak of 2019 novel Coronavirus Diseases (COVID-19) in China. Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention. 2020;41(2):145-51. Available from: https://pubmed.ncbi.nlm.nih.gov/32064853/
Strabelli TMV, Uip DE. Covid-19 e o coração. Arq Bras Cardiol. 2020; 114(4):598-600. DOI: http://dx.doi.org/10.36660/abc.20200209
Wang T, Du Z, Zhu F, Cao Z, An Z, Gao Y et al. Comorbidities and multi-organ injuries in the treatment of COVID-19. Lancet. 2020;395(10228):e52. DOI: https://doi.org/10.1016/S0140-6736(20)30558-4
Yan Y, Yang Y, Wang F, Ren H, Zhang S, Shi X et al. Clinical characteristics and outcomes of patients with severe covid-19 with diabetes. BMJ Open Diab Res Care. 2020;8:e001343. Available from: https://drc.bmj.com/content/8/1/e001343
Sama IE, Ravena A, Santema BT, Goor HV, Maaten JM, Cleland JGF et al. Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors. European Heart Journal. 2020;41:1810-7. Available from: https://academic.oup.com/eurheartj/article/41/19/1810/5834647
Gemes K, Talback M, Modig K, Ahlbom A, Berglund A, Feychting M et al. Burden and prevalence of prognostic factors for severe COVID‑19 in Sweden. European Journal of Epidemiology. 2020; 35:401-9. DOI: https://doi.org/10.1007/s10654-020-00646-z
Abajo FJ, Rodriguez-Martin S, Lerma V, Mejía-Abril G, Aguilar M, García-Luque A et al. Use of renin-angiotensin-aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: A case-population study. Lancet. 2020;395(1):1705-14. Available from: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31030-8/fulltext
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2020 Aquichan
Esta obra está bajo una licencia internacional Creative Commons Atribución-CompartirIgual 4.0.
1. Política propuesta para Revistas que ofrecen Acceso Abierto
Los autores que publican en esta revista están de acuerdo con los siguientes términos:- Sus artículos se publican bajo la licencia Creative Commons Atribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0), por lo cual el usuario es libre de: compartir, copiar y redistribuir el material en cualquier medio o formato, siempre y cuando: dé crédito de manera adecuada, brinde un enlace a la licencia e indique si se han realizado cambios; no use nuestro contenido con propósitos comerciales; y/o remezcle o transforme el material. Recuerde que no tiene los permisos para distribuir el material si fue modificado.
Formato de publicación: impreso y electrónico en Open Acces, bajo la licencia Creative Commons.
